NEW YORK (GenomeWeb News) - Francis Collins will receive the Presidential Medal of Freedom from US president George W. Bush in a White House ceremony on Monday, Nov. 5.
Collins, director of the National Human Genome Research Institute, will receive the award for his involvement in “revolutionizing genetic research” and for his work leading the Human Genome Project, according to NHGRI.
Arthur Beaudet, chair and professor of molecular and human genetics at Baylor College of Medicine, has won the American Society of Human Genetics’ Allan Award.
Beaudet is focused on epigenetics in human disease and genomic imprinting and diseases associated with mental retardation and autism.
BioReliance has named Charles Harwood, who currently is executive chairman, to the post of interim CEO in the wake of the departure of former CEO Tim Derrington.
BioReliance also said that since June three senior executives have joined the company, including David Onions as CSO, David Walker as CFO, and Darryl Goss as VP of Global Process Excellence.
Harwood formerly was president and CEO of Focus Diagnostics and was SVP of venture development at Covance.
Accelrys this week said it has appointed Rohit Shyam to the office of vice president of corporate development and strategy. Shyam had been partner, senior strategy expert, and solution director at Computer Sciences Corporation. Before serving at CSC he was a principal at IBM, a consulting principal at Booz Allen Hamilton, and a private entrepreneur.
Maynard Olson has won the $500,000 Gruber Genetics Prize for developing methods for working with yeast and human genomics, the Peter and Patricia Gruber Foundation said this week.
"When he assembled his physical map of the yeast genome, Maynard developed a new way to piece together the genomic puzzle. He allowed us to mechanize, computerize and organize the process," said David Botstein, a former winner of the Gruber award.
Molly Przeworski, a professor at the University of Chicago, has won the Rosalind Franklin Young Investigator Award for her work on the evolutionary genetics involved in human ability, such as bipedalism and cognition. The award carries a prize of $75,000 over three years.
ProMetic Life Sciences has made some new executive nominations and has reorganized its legal department.
ProMetic said it plans to appoint Bruce Pritchard to VP of corporate development and that he will continue in his role as CFO of the company’s UK subsidiary.
Steve Burton will remain in his office as CEO of ProMetic. Peter Edwardson will take over the job of VP of medical technologies. Stephane Archambault has been promoted to the job of CFO of the ProMetic group.
The company also has abolished its position of general counsel, which was held by the departing Mark Bandrauk. Legal counsels Patrick Sartore and Suzie Guillemette will take over the company’s legal activities. Sartore also has been nominated to be corporate secretary.
Phase Forward has appointed Kenneth Kaitin to its board of directors. Kaitin is director of the Tufts Center for the Study of Drug Development and a professor of medicine at Tufts University School of Medicine.
Laura van ‘t Veer, who is chief research officer at Agendia, has won the 2007 Breast Cancer Research Award from the Pink Ribbon Breast Cancer Foundation, Agendia said this week.
Van ‘t Veer won the award along with her colleagues Martine Piccart-Gebhardt, Fatima Cardoso, and Beppe Viale for their work in a European trial testing the MammaPrint breast cancer assay.
Perlegen this week said it has tapped three new executives to join its staff including Ellen Beasley, Keith Joho, and Jeff Otto.
Beasley will join the company as VP of project management. She comes to the company from Celera, where she held the posts of senior director of therapeutics alliances, senior director of bioinformatics, and director of gene discovery.
Joho steps in as chief information officer after serving as senior VP of research and product management at Ingenuity Systems, and as VP of informatics and bioanalytical operations at SurroMed. Joho also was director of bioinformatics at Abgenix and was at Roche and at the Louisiana State University Medical Center in New Orleans.
Otto comes to the company to take over the role of VP of production operations after having been an executive at Genaissance Pharmaceuticals and at Sequenom.
Cepheid CFO John Sluis will retire on December 31, the company said in its quarterly earnings statement this week. The company is seeking a replacement for Sluis, who will remain a consultant for Cepheid through 2008. Sluis joined Cepheid as VP of finance and CFO.
Myriad Genetics said this week that Jay Moyes will retire from his job as CFO “to pursue his passion – race car driving.” Moyes will be replaced by Jim Evans, who is currently VP of finance at the company.
Tom Ranken plans to give up his role as CEO of VizX Labs and move into a post on the company’s board of directors, while John Thompson will take over the top spot, Ranken said in a letter this week.
Ranken said Thompson has “extensive experience in leadership roles” in a variety of businesses, including working in “venture capital, asset recovery, retail, information technology, financial services, distribution and production.”
Sequenom has appointed John Fazio to its board of directors. Fazio formerly was senior general practice partner at PricewaterhouseCoopers, where he had a 35-year career.
Kathy Yelick will take over duties as director of the US Department of Energy’s National Energy Research Scientific Computing Center in January.
Yelick has been head of the Future Technologies Group at Lawrence Berkeley National Laboratory since 2005 and is a computer science professor at the University of California at Berkeley. She will take over for Horst Simon, who will stay on with NERSC as associate director for computing sciences and director of the computational research division.
Former Deputy Assistant Secretary for Health Nathaniel Stinson has been appointed to the job of acting director of the office of scientific programs at the National Center on Minority Health and Health Disparities. In the role at NCMHD, Stinson will direct oversight of a community based participatory research initiative and loan repayment programs.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.